Omeed M. Hassan, Ammar A. Razzak Mahmood, Ali H. Hamzah, Lubna H. Tahtamouni (2022)
Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects.
ChemistrySelect7: .
DOI: 10.1002/slct.202203726
Abbas A. Ridha Mehihi, Ammar A. Razzak Kubba, Wurood A. Shihab, Lubna H. Tahtamouni (2023)
New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment.
Medicinal Chemistry Research32: 2334.
DOI: 10.1007/s00044-023-03137-4
Omeed M. Hassan, Ammar Kubba, Lubna H. Tahtamouni (2023)
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis,
Docking Study, and Structure Activity Relationship.
Anti-Cancer Agents in Medicinal Chemistry23: 1336.
DOI: 10.2174/1871520623666230227153449
Yahya S. Yaseen, Ammar A.R. Mahmood, Ali H. Abbas, Wurood A. Shihab, Lubna H. Tahtamouni (2023)
New Niflumic Acid Derivatives as EGFR Inhibitors: Design, Synthesis,
In silico Studies, and Anti-proliferative Assessment.
Medicinal Chemistry19: 445.
DOI: 10.2174/1573406419666221219144804
Abdullah Yahya Abdullah Alzahrani, Pratibha Gupta, Vijay Patil, Franz-Josef Meyer-Almes, D. V. Sokolova, V. S. Pokrovsky, C. S. Ramaa (2024)
Diaryl Pyrazoline, 1,3,4-Oxadizole, and 1,2,4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies.
Russian Journal of Bioorganic Chemistry50: 375.
DOI: 10.1134/S1068162024020389
Abbas A. Mehihi, Ammar A. Kubba, Lubna H. Tahtamouni (2023)
Synthesis, Molecular Docking Studies, and In vitro Anticancer Evaluation
of Novel Tolfenamic Acid Derivatives.
Letters in Drug Design & Discovery20: 1393.
DOI: 10.2174/1570180819666220831110423
Imad M. Al-Rubaye, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, Mai F. AlSakhen, Sana I. Kanaan, Khaled M. Saleh, Salem R. Yasin (2024)
In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors.
Results in Chemistry7: 101329.
DOI: 10.1016/j.rechem.2024.101329
Zuhal KARAGÖZ, Umut İbrahim OGUZ, Murat GENÇ (2023)
Synthesis, Solvatochromic Analysis and Theoretical Studies of 3-((1H-benzo[d][1,2,3]triazole-1-yl)methyl)-4- phenylethyl -1H-1,2,4-triazole-5(4H)-thione.
Bitlis Eren Üniversitesi Fen Bilimleri Dergisi12: 568.
DOI: 10.17798/bitlisfen.1279575
Agnieszka Czylkowska, Suneel Lanka, Małgorzata Szczesio, Kamila Czarnecka, Paweł Szymański, Monika Pitucha, Aneta Drabińska, Bruno Cury Camargo, Jacek Szczytko (2022)
New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer Activity.
International Journal of Molecular Sciences23: 9162.
DOI: 10.3390/ijms23169162
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar (2023)
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors.
Journal of Molecular Structure1291: 136021.
DOI: 10.1016/j.molstruc.2023.136021
Subscribe to email alerts for current Article's categories